News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EnBioTec And Tripos Discovery Research Centre (TRPS) Have Entered Into An Agreement To Develop Nuclear Receptor Based Lead Chemicals


11/7/2006 5:42:07 PM

Tokyo, Japan - EnBioTec Laboratories Co., Ltd. based in Tokyo Japan has entered into an agreement with Tripos Discovery Research to co-develop nuclear receptor based lead compounds for drug discovery.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES